79359853 - DRUGOME

Information

  • Trademark
  • 79359853
  • Serial Number
    79359853
  • Registration Number
    7410739
  • Filing Date
    August 19, 2022
    2 years ago
  • Registration Date
    June 11, 2024
    8 months ago
  • Transaction Date
    December 14, 2024
    a month ago
  • Status Date
    June 11, 2024
    8 months ago
  • Published for Opposition Date
    March 26, 2024
    10 months ago
  • Location Date
    June 10, 2024
    8 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    WUDARSKY, MINDY
  • Attorney Docket Number
    16129.0007
    Attorney Name
    B. Brett Heavner
  • Owners
Mark Drawing Code
3
Mark Identification
DRUGOME
Case File Statements
  • DM0000: The mark consists of adjoining incomplete polygons appearing as stylized molecules next to the word "DRUGOME" in stylized lettering.
  • GS0091: Calculating machines, data processing equipment, computers; downloadable computer software for data aggregation automation, database creation, data analysis, data reporting and data visualization; downloadable computer software for providing, analyzing and generating reports; downloadable computer software for data processing; electronic apparatus, electronic equipment, downloadable computer software and programs for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; electronic apparatus, electronic equipment, downloadable computer software and programs for the conversion, analysis, processing, storage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and for clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedical research in support of data analysis and for clinical trial and post-market trial data; downloadable computer search engine software for compiling, accessing and providing updated scientific, medical, pharmaceutical and clinical information, and news information of general interest
  • GS0361: Financial analysis; financial consulting; financial valuations and forecasting; financial analysis of statistics and data; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, and clinical and post-market trials
  • GS0351: Advertising services; business management; business administration; providing office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; statistical analysis and reporting services using artificial intelligence and machine learning for business purposes in the pharmaceutical and biomedical fields; business analysis and statistical analysis of healthcare data, pharmaceuticals, biomedical research, and for clinical trial and post-market data, all the foregoing for business purposes; systematization of data in computer databases; compilation of data for business analysis purposes, namely, compilation of information into computer databases for business data analysis purposes in the fields of healthcare, pharmaceuticals, biomedicine, pharmaceutical and biomedical research and development, clinical trials and post-market data; professional business data analysis and consultancy and statistical analysis for business purposes in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, epidemiological research, pharmacoepidemiological research, post-market trials and research evaluating epidemiological outcomes
  • GS0421: Scientific and technological services, namely, data aggregation automation, database creation, data analysis, data reporting and data visualization in the field of healthcare, pharmaceuticals, biomedical research, and for clinical trial and post-marketing and research and design relating thereto; analysis of technical data by computers, namely, data automation and collection service using proprietary software to evaluate, analyze and collect data, providing use of online non-downloadable software for analyzing data; pharmaceutical, biomedical, and biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials and post-market trials; cloud computing featuring software for use in data aggregation automation, database creation, data analysis, data reporting and data visualization; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticals, biomedicine, pharmaceutical and biopharmaceutical research and development, medical information, clinical trial and post-market trial data for data analysis, data reporting and data visualization; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compiling, accessing, controlling, managing and providing updated scientific, pharmaceutical, medical and clinical information, and news information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analytics, financial analytics and risk management for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services
Case File Event Statements
  • 1/6/2023 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/9/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/13/2023 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/7/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/14/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/15/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/21/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 7/21/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/15/2023 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/22/2024 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/22/2024 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/23/2024 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/17/2024 - 11 months ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/17/2024 - 11 months ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/17/2024 - 11 months ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/17/2024 - 11 months ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/17/2024 - 11 months ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/26/2024 - 10 months ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/26/2024 - 10 months ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/6/2024 - 11 months ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/6/2024 - 11 months ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/7/2024 - 8 months ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 6/11/2024 - 8 months ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/11/2024 - 8 months ago
    24 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/3/2024 - 5 months ago
    26 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 9/11/2024 - 4 months ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 11/21/2024 - 2 months ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/16/2024 - 7 months ago
    25 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 11/21/2024 - 2 months ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/14/2024 - a month ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO